Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Atorvastatin API Companies

ID: MRFR/HC/6413-CR
85 Pages
Vikita Thakur
Last Updated: February 16, 2025
Atorvastatin is a medication used to manage high cholesterol and reduce the risk of heart disease. API (Active Pharmaceutical Ingredient) companies are responsible for producing the active ingredient in atorvastatin.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Atorvastatin API Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.12%
2024 Market Size$ 1.42 Billion
2025 Market Size$ 1.51 Billion
2035 Market Size$ 2.73 Billion

Key Players

Pfizer Inc
Teva Pharmaceutical Industries Ltd
Mylan N.V.
Aurobindo Pharma Limited
Sun Pharmaceutical Industries Ltd
Cipla Limited
Opportunities
  • Rising Geriatric Population
  • Growing Awareness of Cholesterol Management
  • Technological Innovations in Drug Formulation

Top Industry Leaders in the Atorvastatin API Market

<a href=Atorvastatin API Key Companies" width="600" height="300">*Disclaimer: List of key companies in no particular orderLatest Atorvastatin API Companies Update
  • Teva Pharmaceutical Industries Ltd (Israel)

  • Sun Pharmaceutical Industries Ltd (India)

  • Centrient Pharmaceuticals (The Netherlands)

  • Morepen Laboratories Ltd (India)

  • Dr. Reddyโ€™s Laboratories Ltd (India)

  • Anuh Pharma Ltd (India)

  • Jubilant Life Sciences Ltd (India)

  • Ind-Swift Labs Ltd (India)

  • Zhejiang Hisun Pharmaceutical Co Ltd (China)

  • Cadila Pharmaceuticals (India).